Sensitivity of African swine fever virus (ASFV) to heat, alkalinity and peroxide treatment in presence or absence of porcine plasma

• Published in: Veterinary microbiology 2018-06, Vol.219, p.144-149
• Main Authors: Kalmar, I.D., Cay, A.B., Tignon, M.
• Format: Article
• Language: English
• Subjects: Abattoirs; African swine fever; Alkalinity; Asfarviridae; ASFV; Blood; Byproducts; Dilution; Economic impact; Epidemiology; HAPT-treatment; Heat; Heat treatment; Hydrogen peroxide; Inactivation; Livestock; Plasma; Porcine plasma; Pork; SDPP; Sensitivity; Swine; Viral inactivation; Viral infections; Viruses
• ISSN: 0378-1135; 1873-2542
• DOI: 10.1016/j.vetmic.2018.04.025

•Prevention of spread of ASF is critical, biosafety of feed should be considered.•The potential risk of ASFV in blood products sourced from ASF-free areas is minimal.•ASFV is sensitive to inactivation by combined treatment of heat, alkaline pH and peroxide.•HAPT-HP inactivates over 4 log ASFV Lisbon/60 per ml industrially processed porcine plasma. African swine fever virus (ASFV) is a highly resistant viraemic virus with devastating socio-economic impact. Its present epidemiology in Eastern Europe and Russia warrants increased biosecurity measures in Western Europe. This includes proactive precautions on traffic of pork products within and between areas that are officially free from ASF. Namely, delayed notification of clinical signs or introduction of a low-virulent strain in ASF-free areas could result in presence of ASFV in veterinary inspected pork and pork by-products. The present study evaluated sensitivity of ASFV to physical and chemical processing conditions that can be applied on abattoir collected blood for production of spray dried porcine plasma (SDPP). Standard endpoint dilution assays were used to determine the sensitivity of Vero-cell adapted Lisbon/60 strain ASFV to heat treatment (H) at alkaline conditions (A) with or without peroxide (P). Time (T) dependent inactivation was evaluated in presence or absence of porcine plasma. HAPT-treatment at H = 48 °C, A = pH 10.2 and P = 20.6 or 102.9 mM H2O2 during 10 min (T) inactivated (95LCL) 3.35, respectively, 4.17 log10 TCID50 ASFV/ml plasma. In absence of plasma, 6.99 log-inactivation was reached within 5 min. Implementation of HAPT-treatment on plasma from ASFV-free areas provides an additional safety hurdle for derived blood products in the unlikely event that blood from few undetected infected pigs would contaminate pooled veterinary inspected blood. Such an additional processing step in the production of SDPP is thus a valuable precautionary measure to overcome a potential biosecurity-break that may arise during the high-risk phase between transboundary introduction of ASFV and first notification of the disease.